Role of Hypertonic Sodium Lactate in Traumatic Brain Injury Management.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic methodology or primary human data
PubMed 30459851 · doi:10.4103/ajns.AJNS_10_17
What was done
This is a narrative review summarizing the potential physiological mechanisms and therapeutic utility of hypertonic sodium lactate (HSL) as a hyperosmolar fluid in the management of traumatic brain injury (TBI) and elevated intracranial pressure.
What was found
The abstract reports no numerical data, effect estimates, or sample sizes. It qualitatively describes HSL as a promising hyperosmolar therapy that lowers intracranial pressure while providing exogenous lactate to support cerebral energy metabolism during post-injury dysfunction.
Why it matters
HSL offers a conceptual alternative to conventional hyperosmolar agents by coupling intracranial pressure reduction with energetic substrate delivery during post-traumatic cerebral metabolic crisis.
Limits
The abstract describes a non-systematic narrative review providing no primary patient data, study counts, quantitative comparisons, or safety/efficacy endpoints relative to standard osmoprotective therapies.
Cited by
- supports Administering lactate salts can mitigate cerebral swelling and acidosis following traumatic brain injury.